Description
Retatrutide 10mg injectable—discussed in research and late-stage trials as a triple agonist at GLP-1, GIP, and glucagon receptors for metabolic energy balance, adiposity, and glucose regulation. Canada only.
Retatrutide 10mg injectable—discussed in research and late-stage trials as a triple agonist at GLP-1, GIP, and glucagon receptors for metabolic energy balance, adiposity, and glucose regulation. Canada only.
Retatrutide 10mg injectable—discussed in research and late-stage trials as a triple agonist at GLP-1, GIP, and glucagon receptors for metabolic energy balance, adiposity, and glucose regulation. Canada only.
Reviews
There are no reviews yet.